Mesoblast (MESO) Net Income towards Common Stockholders (2014 - 2023)

Mesoblast (MESO) has reported Net Income towards Common Stockholders for 10 consecutive years, with -$21.9 million the latest figure, recorded in Q2 2023.

• Quarterly Net Income towards Common Stockholders fell 2.16% year-over-year to -$21.9 million in Q2 2023, while the trailing twelve-month figure through Dec 2024 was -$21.9 million (up 66.28% YoY) and the FY2025 annual result came in at -$102.1 million, down 16.13% from the prior year.
• Net Income towards Common Stockholders retreated to -$21.9 million in Q2 2023 per MESO's latest filing, from -$18.6 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for MESO reached as high as -$5.5 million in Q3 2019 and fell as low as -$32.6 million in Q2 2020.
• A 5-year average of -$22.0 million and a median of -$22.4 million in 2021 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2019 — Net Income towards Common Stockholders soared 71.87% — and 2020, when it tumbled 347.56%.
• Year by year, Net Income towards Common Stockholders stood at -$24.6 million in 2019, then slipped by 4.51% to -$25.7 million in 2020, then retreated by 0.98% to -$25.9 million in 2021, then increased by 5.62% to -$24.5 million in 2022, then advanced by 10.48% to -$21.9 million in 2023.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$21.9 million, -$18.6 million, and -$24.5 million for Q2 2023, Q1 2023, and Q4 2022 respectively.